1. Home
  2. IMNN vs XELB Comparison

IMNN vs XELB Comparison

Compare IMNN & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$1.04

Market Cap

7.9M

Sector

Health Care

ML Signal

N/A

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

N/A

Current Price

$0.60

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNN
XELB
Founded
1982
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
8.4M
IPO Year
2000
2011

Fundamental Metrics

Financial Performance
Metric
IMNN
XELB
Price
$1.04
$0.60
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
★ $17.00
$4.00
AVG Volume (30 Days)
155.3K
★ 855.2K
Earning Date
11-12-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 48.37
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.13
Revenue Next Year
N/A
$99.55
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$0.52
52 Week High
$5.29
$2.47

Technical Indicators

Market Signals
Indicator
IMNN
XELB
Relative Strength Index (RSI) 25.66 30.39
Support Level N/A N/A
Resistance Level $1.59 $1.16
Average True Range (ATR) 0.12 0.09
MACD -0.03 -0.01
Stochastic Oscillator 15.87 17.12

Price Performance

Historical Comparison
IMNN
XELB

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: